These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
284 related articles for article (PubMed ID: 36573048)
21. Thieno[2,3-d]pyrimidin-4(3H)-one Derivatives of Benzimidazole as Potential Anti- Breast Cancer (MDA-MB-231, MCF-7) Agents. Dimov S; Mavrova AT; Yancheva D; Nikolova B; Tsoneva I Anticancer Agents Med Chem; 2021; 21(11):1441-1450. PubMed ID: 32698751 [TBL] [Abstract][Full Text] [Related]
22. Cytotoxic and Apoptotic Effects of Novel Pyrrolo[2,3-d]Pyrimidine Derivatives Containing Urea Moieties on Cancer Cell Lines. Kilic-Kurt Z; Bakar-Ates F; Karakas B; Kütük Ö Anticancer Agents Med Chem; 2018; 18(9):1303-1312. PubMed ID: 29866023 [TBL] [Abstract][Full Text] [Related]
23. New thieno[3,2-d]pyrimidine-based derivatives: Design, synthesis and biological evaluation as antiproliferative agents, EGFR and ARO inhibitors inducing apoptosis in breast cancer cells. Farghaly AM; AboulWafa OM; Baghdadi HH; Abd El Razik HA; Sedra SMY; Shamaa MM Bioorg Chem; 2021 Oct; 115():105208. PubMed ID: 34365057 [TBL] [Abstract][Full Text] [Related]
24. Synthesis, Biological Assessment, and Structure Activity Relationship Studies of New Flavanones Embodying Chromene Moieties. Assirey E; Alsaggaf A; Naqvi A; Moussa Z; Okasha RM; Afifi TH; Abd-El-Aziz AS Molecules; 2020 Jan; 25(3):. PubMed ID: 32012737 [TBL] [Abstract][Full Text] [Related]
25. Novel thiophenes, thienopyrimidines, and triazolothienopyrimidines for the evaluation of anticancer and augmentation effects of gamma-radiation. Shaaban MA; Ghorab MM; Heiba HI; Kamel MM; Zaher NH; Mostafa MI Arch Pharm (Weinheim); 2010 Jul; 343(7):404-10. PubMed ID: 20379969 [TBL] [Abstract][Full Text] [Related]
26. Design, Synthesis, In Vitro Anti-cancer Activity, ADMET Profile and Molecular Docking of Novel Triazolo[3,4-a]phthalazine Derivatives Targeting VEGFR-2 Enzyme. El-Helby AA; Sakr H; Ayyad RRA; El-Adl K; Ali MM; Khedr F Anticancer Agents Med Chem; 2018; 18(8):1184-1196. PubMed ID: 29651967 [TBL] [Abstract][Full Text] [Related]
27. Design, synthesis and anticancer evaluation of novel spirobenzo[h]chromene and spirochromane derivatives with dual EGFR and B-RAF inhibitory activities. Abdelatef SA; El-Saadi MT; Amin NH; Abdelazeem AH; Omar HA; Abdellatif KRA Eur J Med Chem; 2018 Apr; 150():567-578. PubMed ID: 29549841 [TBL] [Abstract][Full Text] [Related]
28. Synthesis of novel chromeno-annulated cis-fused pyrano[3,4-c]benzopyran and naphtho pyran derivatives via domino aldol-type/hetero Diels-Alder reaction and their cytotoxicity evaluation. Madda J; Venkatesham A; Naveen Kumar B; Nagaiah K; Sujitha P; Ganesh Kumar C; Rao TP; Jagadeesh Babu N Bioorg Med Chem Lett; 2014 Sep; 24(18):4428-4434. PubMed ID: 25172420 [TBL] [Abstract][Full Text] [Related]
29. Synthesis and Reactivity of 6,8-Dibromo-2-ethyl-4H-benzo[d][1,3]oxazin-4-one Towards Nucleophiles and Electrophiles and Their Anticancer Activity. El-Hashash MA; Ali AT; Hussein RA; El-Sayed WM Anticancer Agents Med Chem; 2019; 19(4):538-545. PubMed ID: 30714530 [TBL] [Abstract][Full Text] [Related]
30. Synthesis and Characterization of a New Class of Chromene-Azo Sulfonamide Hybrids as Promising Anticancer Candidates with the Exploration of Their EGFR, Alblewi FF; Alsehli MH; Hritani ZM; Eskandrani A; Alsaedi WH; Alawad MO; Elhenawy AA; Ahmed HY; El-Gaby MSA; Afifi TH; Okasha RM Int J Mol Sci; 2023 Nov; 24(23):. PubMed ID: 38069037 [TBL] [Abstract][Full Text] [Related]
31. Design and Synthesis of Novel Heterocyclic-Based 4 Alblewi FF; Okasha RM; Eskandrani AA; Afifi TH; Mohamed HM; Halawa AH; Fouda AM; Al-Dies AM; Mora A; El-Agrody AM Molecules; 2019 Mar; 24(6):. PubMed ID: 30889862 [TBL] [Abstract][Full Text] [Related]